Clinical trial Recruiting at 1 site Observational Ages 3 Months to 24 Months

Biomarkers in infants with prior neonatal brain injury

Official title: Early Biomarkers Study for Prediction of Executive Dysfunction and Cognitive Outcomes Among Infants With Prior Neonatal Brain Injury

Run by University of Wisconsin, Madison · NCT07413900 · Data updated 2026-11-12

This project will test brain activity and development using games, EEG, and parent questionnaires in infants aged 3–24 months with and without prior neonatal brain injury.

More Premature Birth trials

Quick facts

Study typeObservational
Ages3 Months to 24 Months
SexAll
Enrollment100 (estimated)
SponsorUniversity of Wisconsin, Madison
Academic / other
Locations1 site (Madison, Wisconsin)
StatusRecruiting
StartedMarch 13, 2023
Main results expectedMarch 15, 2030
Study endsMarch 15, 2030
Registry record updatedFebruary 17, 2026
Trial IDNCT07413900 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infants aged 3–24 months and their parent or legal guardian, including those with a neonatal history of HIE, prematurity under 32 weeks, or cerebral palsy, as well as healthy control infants without prior neurological problems, and families able to attend visits at UW–Madison.

Probably not a fit

Infants outside the 3–24 month age range, those with exclusionary neurological conditions for the control group, or families unable to travel to the study site are unlikely to benefit directly from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project enrolls child-parent pairs to compare infants with prior perinatal brain injury (including HIE, very preterm birth, or cerebral palsy) to healthy infants. Participants complete in-person developmental games and cognitive assessments at the University of Wisconsin–Madison hospital, undergo an EEG, and parents fill out questionnaires about behavior and home stress. The protocol is noninterventional and focuses on identifying biomarkers and patterns linked to later cognitive development. Results aim to improve understanding of early markers that predict developmental trajectories.

Why it matters

Potential benefit: If successful, the findings could help identify early signs of altered brain development and support earlier referral to therapies or monitoring.

How similar studies have gone: Previous research using EEG and behavioral testing has shown promise for detecting early developmental differences after neonatal brain injury, but definitive clinical biomarkers remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Child-parent dyads will be recruited to the study.
* Children 3-24 months with and without a history of a perinatal brain injury (PBI) will be included in this study.
* Children with PBIs will include:

  * Children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy,
  * Children born at a premature gestational age (born at less than 32 weeks gestational age).
  * Children diagnosed with cerebral palsy
* Healthy control participants meeting inclusion criteria will include:

  * healthy infants with no prior neurological (brain disorder) history
* For all parents: the only research inclusion criteria is to be the parent or legal guardian of a newborn with perinatal brain injury or healthy control participant.

Exclusion Criteria:

* Healthy infants to be included in the control group will not have:

  * a prior history of brain injury
  * a diagnosis of cerebral palsy
  * a history of a neurological disorder
  * prior admission to the Neonatal Intensive Care Unit (NICU)
* Children with chromosomal abnormalities, genetic syndromes and major congenital malformations will be excluded from both the patient groups and the control group.
* Parents will have no exclusionary criteria.

Where it's running

  • University of Wisconsin Madison University Hospital
    Madison, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.